JPH0452677Y2 - - Google Patents
Info
- Publication number
- JPH0452677Y2 JPH0452677Y2 JP11581687U JP11581687U JPH0452677Y2 JP H0452677 Y2 JPH0452677 Y2 JP H0452677Y2 JP 11581687 U JP11581687 U JP 11581687U JP 11581687 U JP11581687 U JP 11581687U JP H0452677 Y2 JPH0452677 Y2 JP H0452677Y2
- Authority
- JP
- Japan
- Prior art keywords
- liquid storage
- sample liquid
- cell
- section
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Optical Measuring Cells (AREA)
Description
【考案の詳細な説明】
(産業上の利用分野)
本考案は分析用の供試液収容セル、殊に供試液
収容部を2つ又はそれ以上備えている供試液収容
セルに係る。[Detailed Description of the Invention] (Industrial Application Field) The present invention relates to a sample liquid storage cell for analysis, particularly to a test liquid storage cell equipped with two or more sample liquid storage sections.
本考案による供試液収容セルは、ヒトの体液中
における生化学物質を分析する臨床検査において
検体等を収容するために用いられる。 The test liquid storage cell according to the present invention is used to store specimens, etc. in clinical tests for analyzing biochemical substances in human body fluids.
(従来の技術)
ヒトの体液例えば血清、血漿、尿等、殊に一般
的には血清や血漿を検体とし、該検体を分析して
生化学物質を含む各種の物質の量を測定する臨床
検査は各種疾病の病態の程度と推移を診断するた
めに汎用されている。(Prior Art) A clinical test that uses human body fluids such as serum, plasma, urine, etc., particularly serum or plasma, as a specimen and analyzes the specimen to measure the amounts of various substances including biochemical substances. is widely used to diagnose the degree and transition of the pathology of various diseases.
この臨床検査法において、血清または血漿を検
体として用いる場合には、該検体を試験管に採取
し、分析目的に応じた試薬を添加し、反応させて
得た溶液を測定用セルに移してから呈色度、吸光
度、濁度等を測定することにより対象とする物質
の量を測定している。従つて、この種の検査には
反応用容器としての試験管と、測定用容器として
のセルを必要としていた。 In this clinical testing method, when serum or plasma is used as a specimen, the specimen is collected in a test tube, a reagent according to the purpose of analysis is added, and the resulting solution is transferred to a measurement cell. The amount of the target substance is measured by measuring coloration, absorbance, turbidity, etc. Therefore, this type of test requires a test tube as a reaction container and a cell as a measurement container.
(考案が解決しようとする問題点及び考案の目
的)
従来技術方法の実施に際しては反応を試験管で
行ない、測定はセルに入れて行なう都合上、内容
物の移し変えを行なわねばならない点で面倒であ
つた。又試験管等の反応容器は石英又はガラス製
であつて繰返し使用され、従つて洗浄時等におい
て破損の虞れがある点、汚染していれば測定値に
誤差を生じるので充分な保管管理を必要とする点
等に問題があつた。(Problems to be solved by the invention and purpose of the invention) When implementing the conventional method, the reaction is carried out in a test tube and the measurement is carried out in a cell, which is troublesome as the contents must be transferred. It was hot. In addition, reaction containers such as test tubes are made of quartz or glass and are used repeatedly, so there is a risk of them being damaged during cleaning, etc., and if they are contaminated, it will cause errors in the measured values, so they must be stored carefully. There was a problem with what was needed.
従つて、本考案の基本的目的は、分析用の供試
液の反応容器と測定用容器とを兼ねるセルであつ
て、使い棄て可能なセルを供給し、これによつて
操作を簡素化し、又誤差の導入を最小化すること
にある。 Therefore, the basic purpose of the present invention is to provide a disposable cell that serves as both a reaction container and a measurement container for a sample solution for analysis, thereby simplifying the operation, and The aim is to minimize the introduction of errors.
更に、臨床検査としての物質の分析においては
ケトン体比(アセト酢酸/3−ヒドロキシ酪酸)
のように2種類又はそれ以上の物質を測定ことが
必要な場合があるが、従来のように反応用容器と
測定用容器としてそれぞれ別個のものを用いる
と、殊に多検体処理の場合に、検体の取り間違い
や反応試薬の分注に際して誤りが生じる可能性が
あつた。 Furthermore, in the analysis of substances as a clinical test, the ketone body ratio (acetoacetic acid/3-hydroxybutyric acid)
There are cases where it is necessary to measure two or more types of substances, such as in the past, but if separate containers are used as reaction vessels and measurement vessels as in the past, especially when processing multiple samples, There was a possibility that errors could occur when taking the wrong sample or dispensing the reaction reagent.
従つて、本考案の付随的目的は、2種又はそれ
以上の供試液収容部を有し、各供試液収容部が反
応用容器と測定用容器とを兼ねており、多検体処
理の場合にも検体の取り間違いや検体への試薬の
分注時に所定試薬以外の試薬が投入される可能性
を詳しく小ならしめた供試液収容セルを供給する
ことにある。 Therefore, an additional object of the present invention is to have two or more types of sample liquid storage sections, each of which serves as a reaction container and a measurement container, which is useful in processing multiple samples. Another object of the present invention is to provide a sample liquid storage cell in which the possibility that a sample is mistakenly taken or a reagent other than a prescribed reagent is introduced when dispensing a reagent to a sample is reduced in detail.
(問題点を解決し、目的を達成する手段及び作
用)
本考案によれば、上記の問題点は、透明プラス
チツクス製の一体成形物であつて、並んで配置さ
れた少くとも2つの供試液収容部と1つのブラン
ク測定部とを備えており、両側縁の少なくとも一
方に第1の供試液収容部を確認するための目印を
備えていることを特徴とする、分析用の供試液収
容セルにより解決され、上記の目的が達成され
る。(Means and effects for solving the problem and achieving the object) According to the present invention, the above problem can be solved by using an integral molded product made of transparent plastic and at least two test liquids arranged side by side. A sample liquid storage cell for analysis, comprising a storage section and one blank measurement section, and a mark for confirming the first sample liquid storage section on at least one of both side edges. The above objective is achieved.
本考案による供試液収容セル(以下単に「セ
ル」と称することがある)は透明プラスチツク製
であり、コストも比較的低いので、所謂「デイス
ポーザル(使い棄て)」となすことが可能である。
このセルの構成素材であるプラスチツク材料とし
ては検体、試薬及びその反応生成物に侵されず、
紫外領域の透過特性良好なものを選択する必要性
があり、例えばアクリル系樹脂材料殊にポリメチ
ルメタクリレート樹脂が好ましい。 The test liquid storage cell according to the present invention (hereinafter sometimes simply referred to as a "cell") is made of transparent plastic and has a relatively low cost, so it can be made into a so-called "disposable" cell.
The plastic material that is the constituent material of this cell is not attacked by specimens, reagents, and their reaction products.
It is necessary to select a material with good transmission characteristics in the ultraviolet region, and for example, acrylic resin materials, particularly polymethyl methacrylate resins, are preferred.
本考案によるセルにおいて、第1の供試液収容
部確認用の目印が設けられているのは、2種又は
それ以上の物質を測定する場合に、各供試液収容
部に検体例えば血清が分注され、又各供試液収容
部に所定の且つそれぞれ異なつた試薬が分注され
るが、この場合に所定の供試液収容部に所定の試
薬が誤りなく分注されるようになすためであり、
この目印としては耳片状の突起部であることがで
きる。検体と試薬とは反応せしめられ、この反応
液に関して吸光度、濁度等の測定が行なわれる
が、セル自体による測定光の散乱を極力抑えるた
めに、供試液収容部の断面形状は方形であるのが
好ましい。供試液収容部の寸法は少量の検体及び
試薬で測定が可能なように比較的小に、例えば内
寸において幅8mm、奥行8mm程度が好ましく、又
高さは測光用受光部が供試液収容部の下部である
ので問題とはならないが、セルとしての取扱い
(例えばセルの上部を把持することによつて測光
用の受光部に汚染が生じるのを防止する等)やコ
スト等の観点から40mm程度が好ましい。ブランク
測定部は、供試液収容部と同様に構成されている
と、内部に存在する空気がレンズ効果を生じ測定
光の散乱ををもたらすので、空間部として構成さ
れているのが好ましい。 In the cell according to the present invention, the mark for confirming the first sample liquid storage area is provided because when measuring two or more substances, a sample such as serum is dispensed into each sample liquid storage area. In addition, predetermined and different reagents are dispensed into each sample liquid storage part, but in this case, the purpose is to ensure that the predetermined reagent is dispensed into the predetermined sample liquid storage part without error.
This mark may be a lug-shaped protrusion. The sample and reagent are reacted, and the absorbance, turbidity, etc. of this reaction solution are measured.In order to minimize scattering of the measurement light by the cell itself, the cross-sectional shape of the sample solution storage section is rectangular. is preferred. The dimensions of the sample liquid storage part are preferably relatively small so that measurements can be made with a small amount of specimen and reagent, for example, the internal dimensions are about 8 mm in width and 8 mm in depth, and the height is such that the light receiving part for photometry is as tall as the sample liquid storage part. However, from the viewpoint of handling the cell (for example, preventing contamination of the light receiving part for photometry by grasping the top of the cell) and cost, it should be around 40mm. is preferred. If the blank measurement section is configured in the same way as the sample liquid storage section, the air present inside will cause a lens effect and scatter the measurement light, so it is preferably configured as a space.
(実施例)
次に、本考案によるセルの実施の一例について
図面を参照しつつ説明する。(Example) Next, an example of implementation of the cell according to the present invention will be described with reference to the drawings.
図面において、第1図は分析用の本考案による
供試液収容セル10の斜視図であり、第2図は第
1図中の−線断面図である。 In the drawings, FIG. 1 is a perspective view of a sample liquid storage cell 10 for analysis according to the present invention, and FIG. 2 is a sectional view taken along the line -- in FIG.
このセル10はアクリル系の透明樹脂材料であ
るポリメチルメタクリレート樹脂で一体的に成形
されており、基本的には2つの供試液収容部1
2,14と、一つのブランク測定部16とを備え
ている。第1供試液収容部12の外側面には耳片
状の突起部18が形成されており、従つて第2供
試液収容部14から外観において区別し得るよう
になされている。 This cell 10 is integrally molded from polymethyl methacrylate resin, which is an acrylic transparent resin material, and basically consists of two sample liquid storage parts 1.
2 and 14, and one blank measuring section 16. A lug-shaped protrusion 18 is formed on the outer surface of the first sample liquid storage section 12, so that it can be distinguished from the second sample liquid storage section 14 in appearance.
本実施形によるセル10においては、第1供試
液収容部12と第2供試液収容部14とがスペー
サ20a,20bにより離隔され、このスペサー
サの下部に空間部が形成され、この空間部がブラ
ンク測定部16となされている。第1及び第2供
試液収容部12及び14にそれぞれ検体例えば血
清が分注され、次いで各供試液収容部にそれぞれ
別個の試薬が分注される場合に(血清と試薬の分
注順序は逆であつても差支えない)、第1供試液
収容部12にその確認用目印である耳片状の突起
部18が形成されているために並びに第1供試液
収容部12と第2供試液収容部14とがスペーサ
20a,20bにより離隔せしめられているため
に、一方の供試液収容部に分注されるべき試薬が
他方の供試液収容部に分注されるような誤操作の
発生や、一法の供試液収容部に分注されるべき試
薬が両方の供試液収容部に導入されてしまうよう
な誤操作の発生は極力防止することができる。
尚、試薬の分注さえ確実に行なわれるならば、第
1供試液収容部12と第2供試液収容部とが離隔
して配置されている必要性は必ずしもなく、この
場合には第1供試液収容部、第2供試液容部、ブ
ランク測定部の順に並設されることになる。更に
ブランク測定部は前述のように単なる空間部であ
るので、第1供試液収容部12の確認用目印であ
る耳片状突起部18の幅を若干大となし該突起部
18の下部空間をブランク測定部となすこともで
きる。 In the cell 10 according to this embodiment, the first sample liquid storage section 12 and the second sample liquid storage section 14 are separated by spacers 20a and 20b, and a space is formed below the spacer, and this space is used as a blank. It is made into the measurement part 16. When a sample such as serum is dispensed into the first and second sample liquid storage units 12 and 14, and then separate reagents are dispensed into each sample liquid storage unit (the order of dispensing serum and reagents is reversed). ), since the first sample liquid storage section 12 is formed with a lug-shaped protrusion 18 which is a mark for confirmation, and the first sample liquid storage section 12 and the second sample liquid storage section are 14 are separated by the spacers 20a and 20b, it is possible that an erroneous operation such as a reagent to be dispensed into one sample liquid storage section being dispensed into the other sample liquid storage section, or It is possible to prevent as much as possible the occurrence of an erroneous operation in which a reagent to be dispensed into the sample liquid storage section of the method is introduced into both sample liquid storage sections.
In addition, as long as the reagent can be reliably dispensed, it is not necessarily necessary that the first sample liquid storage section 12 and the second sample liquid storage section are arranged apart from each other; The sample liquid storage section, the second test liquid container section, and the blank measurement section are arranged in parallel in this order. Furthermore, since the blank measuring section is just a space as described above, the width of the lug-like protrusion 18, which is a confirmation mark of the first sample liquid storage section 12, is made slightly larger to fill the space below the protrusion 18. It can also be used as a blank measuring section.
尚、本実施形によるセル10において、両供試
液収容部12,14の内容積は同一であり、内寸
は8×8×40mmである。 In the cell 10 according to the present embodiment, the internal volumes of both sample liquid storage sections 12 and 14 are the same, and the internal dimensions are 8 x 8 x 40 mm.
(使用例)
血漿を検体とし、図面に示され且つ実施例に記
載の本考案によるセルを用いて血中ケトン体比を
測定する場合について下記に説明する。(Example of Use) A case will be described below in which plasma is used as a specimen and the blood ketone body ratio is measured using the cell according to the present invention shown in the drawings and described in the Examples.
1 検体の調整
採取した動脈血に抗凝固剤としてヘパリンを添
加した後、直ちに4℃、3000rpmで10分間遠心し
て得た血漿に6%過塩素酸溶液を同量添加し、2
〜3秒間攪拌した後に10分間以上氷冷し、4℃、
3000rpmで10分間遠心し、上清を採取して検体と
する(用時迄保存、氷冷下では48時間、−20℃で
は3日間、−70℃では30日間安定)。1 Preparation of specimen After adding heparin as an anticoagulant to the collected arterial blood, immediately centrifuge at 4°C and 3000 rpm for 10 minutes. Add the same amount of 6% perchloric acid solution to the plasma obtained.
After stirring for ~3 seconds, cool on ice for at least 10 minutes, and cool at 4℃.
Centrifuge at 3000 rpm for 10 minutes, collect the supernatant, and use it as a specimen (store until use; stable for 48 hours on ice, 3 days at -20°C, and 30 days at -70°C).
2 試薬
a 共通の酸素試液
3−ヒドロキシ酪酸脱水素酵素の原液1.7mlに
精製水1.5mlを混和して調製(氷冷保存すれば30
日間安定)。2 Reagent a Common oxygen test solution Prepared by mixing 1.7 ml of stock solution of 3-hydroxybutyrate dehydrogenase with 1.5 ml of purified water (if stored on ice,
(stable for days).
b アセト酢酸測定用の補酵素試液(A)
β−NADH凍結乾燥品1.2mgにトリエタノール
アミン4mlを混和して調製(氷冷保存すれば10日
間安定)。b Coenzyme test solution for measuring acetoacetic acid (A) Prepared by mixing 4 ml of triethanolamine with 1.2 mg of lyophilized β-NADH (stable for 10 days if stored on ice).
c 3−ヒドロキシ酪酸測定用の補酵素試液(B)
β−NAD+凍結乾燥品40.4mgにトリス塩緩衝液
8mlを混和して調製(氷冷保存すれば20日間安
定)。c Coenzyme test solution for measuring 3-hydroxybutyric acid (B) Prepared by mixing 40.4 mg of β-NAD + lyophilized product with 8 ml of Tris salt buffer (stable for 20 days if stored on ice).
3 測定操作
a セル10の第1供試液収容部12に補酵素試
液Aを0.25ml分注し、又第2供試液収容部14
に補酵素試液Bを0.25ml分注し、第1及び第2
供試液収容部12,14に検体をそれぞれ0.5
ml分注し、軽く混和した後37℃に加温してイン
キユベートする(5分間)。次いで第1及び第
2供試液収容部12,14並びにブランク測定
部16を波長340nmで測光して吸光度を測定す
る。3 Measuring operation a Dispense 0.25 ml of coenzyme test solution A into the first test solution storage section 12 of the cell 10, and also dispense 0.25 ml of coenzyme test solution A into the second test solution storage section 14.
Dispense 0.25 ml of coenzyme test solution B into the first and second
Place 0.5 of the sample in the sample liquid storage parts 12 and 14, respectively.
Dispense 1 ml, mix gently, and incubate at 37°C (5 minutes). Next, the first and second sample liquid storage sections 12, 14 and the blank measuring section 16 are photometered at a wavelength of 340 nm to measure the absorbance.
b 次に、第1及び第2供試液収容部12,14
に酵素試液をそれぞれ0.05ml分注し、軽く混和
後37℃に加温してインキユベートする(15分
間)。その後上記a項と同様にして吸光度をそ
れぞれ測定する。b Next, the first and second sample liquid storage sections 12 and 14
Dispense 0.05 ml of the enzyme test solution into each tube, mix gently, and incubate at 37℃ for 15 minutes. Thereafter, the absorbance is measured in the same manner as in section a above.
c アセト酢酸濃度及び3−ヒドロキシ酪酸濃度
並びにその比であるケトン体比は上記の吸光度
測定値を基にして周知の方法で求めることがで
きる。c The acetoacetic acid concentration, 3-hydroxybutyric acid concentration, and the ketone body ratio, which is the ratio thereof, can be determined by a well-known method based on the above-mentioned absorbance measurement values.
(考案の効果)
本考案による分析用の供試液収容セルはプラス
チツクス材料製であつて比較的廉価であるために
使い棄てとすることができる。このセルは供試液
収容部を少なくとも2つ備えているので同一の検
体をこれら供試液収容部に分注し、それぞれ別個
の試薬を導入することにより2種類又はそれ以上
の物質を同時に分析するために用いることができ
る。(Effects of the invention) The cell for storing a sample liquid for analysis according to the invention is made of plastic material and is relatively inexpensive, so it can be disposable. Since this cell is equipped with at least two sample liquid storage areas, two or more substances can be analyzed simultaneously by dispensing the same sample into these sample liquid storage areas and introducing separate reagents into each of these sample liquid storage areas. It can be used for.
例えば所謂「ケトン体比」即ちアセト酢酸/3
−ヒドロキシ酪酸比は、従来は糖尿病の臨床診断
の指標として、現在では肝臓を含む各種臓器の不
全に関する診断指標として重要なものとなつてい
るが、本考案によるセルはこのような場合の測定
に用いるものとして極めて好適であり、検体の取
り間違いや試薬の入れ間違いを有効に防止するこ
とができる。 For example, the so-called "ketone body ratio", that is, acetoacetic acid/3
-Hydroxybutyric acid ratio has traditionally been used as an index for clinical diagnosis of diabetes, and now it has become an important diagnostic index for failure of various organs including the liver.The cell according to the present invention is suitable for measurement in such cases. It is extremely suitable for use, and can effectively prevent incorrect collection of specimens and incorrect insertion of reagents.
第1図は生化学的分析用の本考案による供試液
収容セルの斜視図、第2図は第1図中の−線
による断面図である。
10……供試液収容セル、12,14……供試
液収容部、16……ブランク測定部、18……第
1供試液収容部12確認用の目印(耳片状の突起
部)、20a,20b……スペーサ。
FIG. 1 is a perspective view of a sample liquid storage cell according to the present invention for biochemical analysis, and FIG. 2 is a sectional view taken along the - line in FIG. DESCRIPTION OF SYMBOLS 10... Test liquid storage cell, 12, 14... Test solution storage section, 16... Blank measurement section, 18... Mark for checking the first test solution storage section 12 (lug-shaped protrusion), 20a, 20b...Spacer.
Claims (1)
て、並んで配置された少くとも2つの供試液収
容部と1つのブランク測定部とを備えており、
両側縁の少くとも一方に第1の供試液収容部を
確認するための目印を備えていることを特徴と
する、分析用の供試液収容セル。 (2) 第1の供試液収容部確認用の目印が耳片状の
突起部であることを特徴とする、実用新案登録
請求の範囲第1項に記載の分析用の供試液収容
セル。 (3) 供試液収容部の横断面形状が方形であり且つ
同一の寸法のものであり、この供試液収容部が
2つ設けられていてスペーサにより離隔されて
おり、両供試液収容部の下部間が空間部となさ
れており、この空間部がブランク測定部を形成
していることを特徴とする、実用新案登録請求
の範囲第1項又は第2項に記載の分析用の供試
液収容セル。[Claims for Utility Model Registration] (1) An integrally molded product made of transparent plastic, comprising at least two sample liquid storage sections and one blank measurement section arranged side by side,
A sample liquid storage cell for analysis, characterized in that a mark for confirming a first sample liquid storage section is provided on at least one of both side edges. (2) The sample liquid storage cell for analysis according to claim 1, wherein the mark for confirming the first sample liquid storage part is a lug-shaped protrusion. (3) The cross-sectional shape of the sample liquid storage section is rectangular and has the same dimensions, and there are two sample liquid storage sections separated by a spacer, and the lower part of both sample liquid storage sections is A cell for storing a sample liquid for analysis according to claim 1 or 2 of the utility model registration claim, characterized in that a space is formed between the cells and the space forms a blank measuring section. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11581687U JPH0452677Y2 (en) | 1987-07-30 | 1987-07-30 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11581687U JPH0452677Y2 (en) | 1987-07-30 | 1987-07-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6421353U JPS6421353U (en) | 1989-02-02 |
| JPH0452677Y2 true JPH0452677Y2 (en) | 1992-12-10 |
Family
ID=31357806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11581687U Expired JPH0452677Y2 (en) | 1987-07-30 | 1987-07-30 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0452677Y2 (en) |
-
1987
- 1987-07-30 JP JP11581687U patent/JPH0452677Y2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6421353U (en) | 1989-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Voss et al. | Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine/DTNB procedure | |
| CN1914511B (en) | Hematocrit and analyte concentration determination | |
| Lott et al. | Evaluation of the Coomassie Brilliant Blue G-250 method for urinary protein. | |
| US4251159A (en) | Disposable multi-chamber cuvette | |
| Smith et al. | The relationship between lead in plasma and whole blood in women | |
| US3733179A (en) | Method and apparatus for the quantitative determination of blood chemicals in blood derivatives | |
| Coe et al. | Variations in vitreous humor chemical values as a result of instrumentation | |
| US20050037505A1 (en) | Spectroscopic method and apparatus for analyte measurement | |
| US7449339B2 (en) | Spectroscopic method and apparatus for total hemoglobin measurement | |
| Westgard et al. | Determination of serum albumin with the" SMA 12/60" by a bromcresol green dye-binding method | |
| Levinson et al. | Measuring hemoglobin in plasma by reaction with tetramethylbenzidine. | |
| US3890099A (en) | Colorimetric assay for urea | |
| JPS6350743A (en) | Analysis of hemolyzed blood specimen | |
| Sykes et al. | Laboratory measurement of bilirubin | |
| JPH0452677Y2 (en) | ||
| Lott et al. | Evaluation of an automated urine chemistry reagent‐strip analyzer | |
| Bandi et al. | Extended clinical trial and evaluation of glucose determination with the Eastman Kodak Ektachem GLU/BUN Analyzer. | |
| Saifer et al. | Rapid system of microchemical analysis for the clinical laboratory | |
| US20070196927A1 (en) | Method For Qualitative And/Or Quantitative Detection Of Polyethylene Glycols In Biological Fluids | |
| KINGSLEY et al. | Procedure for serum protein determinations with a triphosphate biuret reagent | |
| JPS5845562A (en) | Method of measuring beta-lipoprotein fraction in body fluid and measurement reagent | |
| Grinstead et al. | The Ames Clinitek 200/Multistix 9 urinalysis method compared with manual and microscopic methods. | |
| Levinson | Direct determination of serum chloride with a semiautomated discrete analyzer. | |
| Costello et al. | Multilayer film analysis: evaluation of ion-selective electrolyte slides. | |
| Landt et al. | Monoject Samplette capillary blood container with serum separator evaluated for collection of specimens for therapeutic drug assays and common clinical-chemical tests. |